ongterm follow-up of patients treated with Lenti-D for an inherited brain disorder

Not Applicable

Recruiting

• Conditions: Disorders of fatty-acid metabolism; E71.3

• Registration Number: RBR-72wbbg
• Lead Sponsor: Blanchard y Asociados

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-03-10
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Male
• Target Recruitment: Not specified

Inclusion Criteria

Provision of written informed consent for this study by the subject or subject’s parent(s)/legal guardian(s) and written informed assent by subject, if applicable. Have received Lenti-D Drug Product in a parent clinical study. Able to comply with study requirements

Exclusion Criteria

There are no exclusion criteria for this Study.

Study & Design

• Study Type: Observational
• Study Design: Not specified